I read your recent column on shingles. I am 66 and in fairly good health. I had both Shingrix shots about five years ago and take hydroxyurea for polycythemia vera (PV).
Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with improved tolerability and accessibility, today ...
Curevo’s CEO, George Simeon, will discuss updated data from Curevo’s 876-patient head-to-head trial of amezosvatein, a non-mRNA adjuvanted subunit vaccine for shingles, versus Shingrix ®.
—Older adults are advised to protect themselves from flu and shingles, but is offering adjuvanted vaccinations for both conditions simultaneously an acceptable option? Expedient, yes. Safe…?